136 related articles for article (PubMed ID: 36194478)
1. Bayesian forecasting of tumor size metrics and overall survival.
Krishnan SM; Friberg LE
CPT Pharmacometrics Syst Pharmacol; 2022 Dec; 11(12):1604-1613. PubMed ID: 36194478
[TBL] [Abstract][Full Text] [Related]
2. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study.
Claret L; Pentafragka C; Karovic S; Zhao B; Schwartz LH; Maitland ML; Bruno R
Cancer Chemother Pharmacol; 2018 Jul; 82(1):49-54. PubMed ID: 29700575
[TBL] [Abstract][Full Text] [Related]
4. Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation.
Han K; Claret L; Sandler A; Das A; Jin J; Bruno R
BMC Cancer; 2016 Jul; 16():473. PubMed ID: 27412292
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.
An MW; Dong X; Meyers J; Han Y; Grothey A; Bogaerts J; Sargent DJ; Mandrekar SJ;
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26296640
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
Proost JH; Schiere S; Eleveld DJ; Wierda JM
Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
[TBL] [Abstract][Full Text] [Related]
7. The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.
Chan PL; Jacqmin P; Lavielle M; McFadyen L; Weatherley B
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):41-61. PubMed ID: 21088872
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of tumor-size response metrics to predict overall survival in Western and Chinese patients with first-line metastatic colorectal cancer.
Claret L; Gupta M; Han K; Joshi A; Sarapa N; He J; Powell B; Bruno R
J Clin Oncol; 2013 Jun; 31(17):2110-4. PubMed ID: 23650411
[TBL] [Abstract][Full Text] [Related]
9. Impact of random and fixed (optimal) sampling approach on the Bayesian estimation of clearance.
Mahmood I
Int J Clin Pharmacol Ther; 2003 Sep; 41(9):392-6. PubMed ID: 14526763
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.
Gotta V; Widmer N; Montemurro M; Leyvraz S; Haouala A; Decosterd LA; Csajka C; Buclin T
Clin Pharmacokinet; 2012 Mar; 51(3):187-201. PubMed ID: 22339450
[TBL] [Abstract][Full Text] [Related]
12. Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study.
Ngwa JS; Cabral HJ; Cheng DM; Gagnon DR; LaValley MP; Cupples LA
BMC Med Res Methodol; 2021 Feb; 21(1):29. PubMed ID: 33568059
[TBL] [Abstract][Full Text] [Related]
13. Continuous updating of individual headache forecasting models using Bayesian methods.
Houle TT; Deng H; Tegeler CH; Turner DP
Headache; 2021 Sep; 61(8):1264-1273. PubMed ID: 34435659
[TBL] [Abstract][Full Text] [Related]
14. Estimation of population pharmacokinetic parameters in the presence of non-compliance.
Mu S; Ludden TM
J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian formulation of the Kalman filter applied to the estimation of individual pharmacokinetic parameters.
Botsman K; Tickle K; Smith JD
Comput Biomed Res; 1997 Apr; 30(2):83-94. PubMed ID: 9167082
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Bayesian estimation of pharmacokinetic parameters.
Tsuchiwata S; Mihara K; Yafune A; Ogata H
Ther Drug Monit; 2005 Feb; 27(1):18-24. PubMed ID: 15665741
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator.
Rousseau A; Léger F; Le Meur Y; Saint-Marcoux F; Paintaud G; Buchler M; Marquet P
Ther Drug Monit; 2004 Feb; 26(1):23-30. PubMed ID: 14749545
[TBL] [Abstract][Full Text] [Related]
18. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
[TBL] [Abstract][Full Text] [Related]
19. Using Bayesian tissue classification to improve the accuracy of vestibular schwannoma volume and growth measurement.
Vokurka EA; Herwadkar A; Thacker NA; Ramsden RT; Jackson A
AJNR Am J Neuroradiol; 2002 Mar; 23(3):459-67. PubMed ID: 11901019
[TBL] [Abstract][Full Text] [Related]
20. Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation.
Fukudo M; Yano I; Fukatsu S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
Clin Pharmacokinet; 2003; 42(13):1161-78. PubMed ID: 14531726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
